Figueiredo, Ana http://orcid.org/0000-0002-7949-8440
Rodrigues, Ana http://orcid.org/0000-0003-2955-0551
Gaspar, Carina http://orcid.org/0000-0002-8679-6104
Felizardo, Margarida http://orcid.org/0000-0003-3853-0616
Funding for this research was provided by:
Pfizer
Article History
Accepted: 27 August 2023
First Online: 3 October 2023
Declarations
:
: The study was funded by Pfizer and the development of this manuscript was proposed to all authors by the funding source. Pfizer had no role in data collection or in the decision of the content of the article. The open access fee was sponsored by Pfizer.
: AF declares that she has received honoraria from BMS, Boehringer, MSD, Pfizer, AstraZeneca, Roche, and Takeda. AR declares that she has received honoraria from BMS, MSD, Merck, AstraZeneca, and Pfizer. CG declares that she has received honoraria from MSD, BMS, Takeda, Pfizer, AstraZeneca, and Jansen. MF declares that she has received honoraria from MSD, AstraZeneca, Merck, Takeda, and Pfizer. All authors were paid consultants to Pfizer in connection with the development of this manuscript.
: All data generated or analysed during this study are included in this published article and its supplementary information files.
: This study was based on a questionnaire related to physicians’ clinical practice and, although it involved human participants, it did not include any intervention. Therefore, institutional review board approval was not deemed necessary. This study was conducted in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: Not applicable.
: Not applicable.
: Not applicable.
: The authors confirm their contributions to the paper as follows: preparation of the questionnaire, data collection and analysis, and paper conception were performed by all authors. The first draft of the manuscript was critically revised by all authors. All authors confirm that they have read and approved the final version of the manuscript.